• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.09% Nasdaq Up0.98%

    AVEO Pharmaceuticals, Inc. (AVEO)

    -NasdaqGS
    1.51 0.00(0.00%) 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 134   116   872   1,846  
    Cost of Revenue -   -   -   -  
    Gross Profit 134   116   872   1,846  
    Operating Expenses
    Research Development2,695  8,702  8,485  9,300  
    Selling General and Administrative3,255  3,104  5,085  4,845  
    Non Recurring4,333  1,303  1,401  5,166  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (10,149) (12,993) (14,099) (17,465)
    Income from Continuing Operations
    Total Other Income/Expenses Net(9)(35)102  8  
    Earnings Before Interest And Taxes(10,158)(13,028)(13,997)(17,457)
    Interest Expense716  866  439  502  
    Income Before Tax(10,874)(13,894)(14,436)(17,959)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(10,874)(13,894)(14,436)(17,959)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (10,874) (13,894) (14,436) (17,959)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (10,874) (13,894) (14,436) (17,959)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.